Ruparel, Shivani <br/><br/>
The cytochrome P450 inhibitor, ketoconazole, inhibits oxidized linoleic acid metabolite-mediated peripheral inflammatory pain.  [electronic resource] 

 -  Molecular pain  Sep 2012 
 - 73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1744-8069 
<br/><br/><label>Standard No.: </label>10.1186/1744-8069-8-73  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies--pharmacology<br/>Behavior, Animal--drug effects<br/>Cytochrome P-450 Enzyme Inhibitors<br/>Cytochrome P-450 Enzyme System--metabolism<br/>Enzyme Inhibitors--pharmacology<br/>Freund's Adjuvant<br/>Hot Temperature<br/>Hyperalgesia--drug therapy<br/>Inflammation--complications<br/>Ketoconazole--pharmacology<br/>Linoleic Acid--metabolism<br/>Linoleic Acids--immunology<br/>Linoleic Acids, Conjugated--immunology<br/>Mice<br/>Mice, Inbred C57BL<br/>Nociception--drug effects<br/>Oxidation-Reduction--drug effects<br/>Pain--complications<br/>Rats<br/>Rats, Sprague-Dawley<br/>TRPV Cation Channels--agonists